Reunion Neuroscience Inc. (REUN)
Reunion Neuroscience Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $1.12, down 0.89% on the session, giving a market capitalisation of $13.1M. On trailing twelve-month figures it carries a trailing P/E of -0.27, a net margin of 0.0%. Its beta of 4.20 implies it has historically moved more than the broad market.
Field Trip Health Ltd. is a North American company specializing in the development and delivery of psychedelic-assisted therapies. The organization operates Field Trip Health Centres, which offer psychedelic-based treatments, and provides digital applications under the Field Trip brand. Additionally, its Field Trip Discovery division focuses on researching and creating next-generation psychedelic molecules. The company also administers ketamine-assisted therapy to address various conditions, including depression, anxiety, and addiction. Established in 2008, Field Trip Health Ltd. is based in Toronto, Canada.
Reunion Neuroscience Inc. is most often compared with the following Healthcare names: